This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Stability of dexmedetomidine, ketamine and lidocaine combined injectable solution for analgesia.
European journal of hospital pharmacy : science and practice · 2025 · senior author
Y-site simulation compatibility study of 10% calcium salts with various injectable solutions during toxicological resuscitation.
European journal of hospital pharmacy : science and practice · 2024 · senior author
Visual compatibility and particle counter evaluations of syringes of intramuscular psychotropic coadministered solutions.
European journal of hospital pharmacy : science and practice · 2023
Latest funding
- $1,800,000
Precision medicine study of type 2 diabetes in the COLCOT-T2D trial
CIHR · 2021 · Co-investigator
- $10,000
Precision medicine study of type 2 diabetes in the COLCOT-T2D trial
CIHR · 2020 · Co-investigator
- $883,575
Study of the effect of sex on drugs dosing, concentrations and pharmacogenomics.
CIHR · 2019 · Principal investigator
3 publications.
Stability of dexmedetomidine, ketamine and lidocaine combined injectable solution for analgesia.
St-Jean I, Hachemi D, Friciu M, Forest JM, Belliveau M, Williamson D, Leclair G
Y-site simulation compatibility study of 10% calcium salts with various injectable solutions during toxicological resuscitation.
Hamelin A, Thompson-Desormeaux F, Elliott A, Friciu M, Forest JM, Leclair G
Visual compatibility and particle counter evaluations of syringes of intramuscular psychotropic coadministered solutions.
Djerroud L, Leclair G, Sullivan T, Dagenais-Beaulé V
Precision medicine study of type 2 diabetes in the COLCOT-T2D trial
Principal investigators: Dubé, Marie-Pierre; Carpentier, André C; Lewis, Gary F; Tardif, Jean-Claude
Keywords: Colchicine; Diabetes; Gender; Genomics; Pharmacogenomics; Proteomics
Precision medicine study of type 2 diabetes in the COLCOT-T2D trial
Principal investigators: Dubé, Marie-Pierre; Carpentier, André C; Lewis, Gary F; Tardif, Jean-Claude
Keywords: Clinical Trial; Colchicine; Drug Concentrations; Drug Metabolites; Genomics; Gwas; Pharmacogenomics; Precision Medicine; Proteomics; Type 2 Diabetes
Study of the effect of sex on drugs dosing, concentrations and pharmacogenomics.
Principal investigators: De Denus, Simon; Dubé, Marie-Pierre; Leclair, Grégoire
Keywords: Drug Interactions; Medications; Pharmacogenomic; Sex
Development of a nystatin nanosuspension formulation using high pressure homogenisation
Principal investigators: Leclair, Grégoire
Évaluation prédictive des propriétés de dissolutions de comprimés pharmaceutiques à l'aide de tests en cours de procédé
Principal investigators: Leclair, Grégoire
Pilot-scale production of a nystatin nanosuspension with improved antifungal efficacy
Principal investigators: Leclair, Grégoire
Study of the permeability of cellular membranes using proteoliposomes
Principal investigators: Leclair, Grégoire
Improved membrane permeation assays for drug bioavailability assessment
Principal investigators: Marcotte, Isabelle
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.